These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 9586899)
1. Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma. Redman BG; Smith DC; Flaherty L; Du W; Hussain M J Clin Oncol; 1998 May; 16(5):1844-8. PubMed ID: 9586899 [TBL] [Abstract][Full Text] [Related]
2. Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Ozols RF J Clin Oncol; 1995 Aug; 13(8):1860-70. PubMed ID: 7543559 [TBL] [Abstract][Full Text] [Related]
3. Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point. Small EJ; Lew D; Redman BG; Petrylak DP; Hammond N; Gross HM; Eastham JA; Crawford ED J Clin Oncol; 2000 Jul; 18(13):2537-44. PubMed ID: 10893284 [TBL] [Abstract][Full Text] [Related]
4. Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma: a Southwest Oncology Group study. Vaishampayan UN; Faulkner JR; Small EJ; Redman BG; Keiser WL; Petrylak DP; Crawford ED Cancer; 2005 Oct; 104(8):1627-32. PubMed ID: 16138364 [TBL] [Abstract][Full Text] [Related]
5. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma. Edelman MJ; Meyers FJ; Houston J; Lauder I Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226 [TBL] [Abstract][Full Text] [Related]
6. Phase II trial of weekly paclitaxel and carboplatin chemotherapy in patients with advanced transitional cell cancer. Johannsen M; Sachs M; Roigas J; Hinke A; Staack A; Loening SA; Schnorr D; Wille AH Eur Urol; 2005 Aug; 48(2):246-51. PubMed ID: 15963636 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen. Vaughn DJ; Malkowicz SB; Zoltick B; Mick R; Ramchandani P; Holroyde C; Armstead B; Fox K; Wein A J Clin Oncol; 1998 Jan; 16(1):255-60. PubMed ID: 9440750 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience. Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Johnson S; Ozols RF Semin Oncol; 1995 Aug; 22(4 Suppl 9):18-29. PubMed ID: 7544025 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial. Pectasides D; Visvikis A; Aspropotamitis A; Halikia A; Karvounis N; Dimitriadis M; Athanassiou A Eur J Cancer; 2000 Jan; 36(1):74-9. PubMed ID: 10741298 [TBL] [Abstract][Full Text] [Related]
10. Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma. Alva A; Daignault S; Smith DC; Hussain M Invest New Drugs; 2014 Feb; 32(1):188-94. PubMed ID: 24318901 [TBL] [Abstract][Full Text] [Related]
11. A phase II evaluation of weekly paclitaxel plus carboplatin in advanced urothelial cancer. Friedland DM; Dakhil S; Hollen C; Gregurich MA; Asmar L Cancer Invest; 2004; 22(3):374-82. PubMed ID: 15493358 [TBL] [Abstract][Full Text] [Related]
12. Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial. Bajorin DF; McCaffrey JA; Hilton S; Mazumdar M; Kelly WK; Scher HI; Spicer J; Herr H; Higgins G J Clin Oncol; 1998 Aug; 16(8):2722-7. PubMed ID: 9704723 [TBL] [Abstract][Full Text] [Related]
13. Salvage treatment with low-dose weekly paclitaxel in elderly or poor performance status patients with metastatic urothelial carcinoma. Han JJ; Kim YJ; Kim JW; Chang H; Lee JO; Lee KW; Jeong CW; Kim JH; Hong SK; Bang SM; Byun SS; Lee SE; Lee JS Tumori; 2014; 100(4):439-45. PubMed ID: 25296594 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study. Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219 [TBL] [Abstract][Full Text] [Related]
15. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC). Glorieux P; Ortmanns P; Marien S; Degives R; Degraeve D; Potvin M; Grauwels D; Schallier D Anticancer Res; 2001; 21(2B):1487-94. PubMed ID: 11396237 [TBL] [Abstract][Full Text] [Related]
16. Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedules. Bajorin DF; McCaffrey JA; Dodd PM; Hilton S; Mazumdar M; Kelly WK; Herr H; Scher HI; Icasiano E; Higgins G Cancer; 2000 Apr; 88(7):1671-8. PubMed ID: 10738226 [TBL] [Abstract][Full Text] [Related]
17. A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer. Kelly K; Pan Z; Murphy J; Huffman DH; Bunn PA Clin Cancer Res; 1997 Jul; 3(7):1117-23. PubMed ID: 9815791 [TBL] [Abstract][Full Text] [Related]
18. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833 [TBL] [Abstract][Full Text] [Related]
19. Paclitaxel Carboplatin chemotherapy as a second-line chemotherapy for advanced platinum resistant urothelial cancer in Japanese cases. Soga N; Onishi T; Arima K; Sugimura Y Int J Urol; 2007 Sep; 14(9):828-32. PubMed ID: 17760750 [TBL] [Abstract][Full Text] [Related]
20. Phase I and pharmacologic study of the combination paclitaxel and carboplatin as first-line chemotherapy in stage III and IV ovarian cancer. Huizing MT; van Warmerdam LJ; Rosing H; Schaefers MC; Lai A; Helmerhorst TJ; Veenhof CH; Birkhofer MJ; Rodenhuis S; Beijnen JH; ten Bokkel Huinink WW J Clin Oncol; 1997 May; 15(5):1953-64. PubMed ID: 9164207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]